KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Edwards Lifesciences (EW) EPS (Basic) (2016 - 2026)

Edwards Lifesciences has reported EPS (Basic) over the past 17 years, most recently at $0.13 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 77.59% year-over-year to $0.13; the TTM value through Dec 2025 reached $1.82, down 22.22%, while the annual FY2025 figure was $1.81, 74.07% down from the prior year.
  • EPS (Basic) for Q4 2025 was $0.13 at Edwards Lifesciences, down from $0.5 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $0.79 in Q2 2021 and troughed at $0.13 in Q4 2025.
  • A 5-year average of $0.56 and a median of $0.55 in 2021 define the central range for EPS (Basic).
  • Biggest five-year swings in EPS (Basic): soared 495.0% in 2021 and later crashed 77.59% in 2025.
  • Year by year, EPS (Basic) stood at $0.54 in 2021, then increased by 20.37% to $0.65 in 2022, then dropped by 15.38% to $0.55 in 2023, then increased by 5.45% to $0.58 in 2024, then crashed by 77.59% to $0.13 in 2025.
  • Business Quant data shows EPS (Basic) for EW at $0.13 in Q4 2025, $0.5 in Q3 2025, and $0.58 in Q2 2025.